It seems too good to be true, doesnt it
Full AI Image Prompt: Create a clean medical infographic titled GHK-Cu Claim Strength Matrix. Use a two-axis matrix with the horizontal axis labeled Evidence strength and the vertical axis labeled Claim scope. Place labeled cards: Topical skin aging, Wound-care context, Hair growth, Injectable regeneration, and Systemic anti-aging. Position topical skin aging and wound-care context closer to stronger evidence, hair growth in a limited or indirect evidence area, and injectable regeneration and systemic anti-aging in an uncertain evidence-gap area
Ther Adv Drug Saf 4(1):57 [DOI] [PMC free article] [PubMed] [Google Scholar] Duan LP, Wang HH, Ohashi A, Wang DQ (2006) Role of intestinal sterol transporters Abcg5, Abcg8, and Npc1l1 in cholesterol absorption in mice: gender and age effects
Try Again Verification failed
The ASCO guidelines identify duloxetine as the sole recommended treatment for CIPN, particularly in cases associated with oxaliplatin and paclitaxel, due to its proven efficacy in alleviating neuropathic symptoms (Hershman et al., 2014
